Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022

SELL
$22.17 - $51.8 $292,001 - $682,257
-13,171 Reduced 21.53%
48,000 $2.48 Million
Q2 2022

Aug 15, 2022

BUY
$15.36 - $27.51 $402,001 - $719,991
26,172 Added 74.78%
61,171 $1.52 Million
Q1 2022

May 16, 2022

SELL
$22.22 - $39.12 $237,687 - $418,466
-10,697 Reduced 23.41%
34,999 $877,000
Q3 2021

Nov 15, 2021

BUY
$13.18 - $19.83 $602,273 - $906,151
45,696 New
45,696 $781,000
Q2 2021

Aug 16, 2021

SELL
$9.59 - $50.88 $265,211 - $1.41 Million
-27,655 Closed
0 $0
Q2 2020

Aug 17, 2020

SELL
$38.58 - $65.07 $599,224 - $1.01 Million
-15,532 Reduced 35.96%
27,655 $1.59 Million
Q1 2020

May 13, 2020

BUY
$32.73 - $50.78 $87,029 - $135,024
2,659 Added 6.56%
43,187 $1.74 Million
Q4 2019

Feb 14, 2020

SELL
$6.81 - $39.55 $464,925 - $2.7 Million
-68,271 Reduced 62.75%
40,528 $1.6 Million
Q2 2019

Aug 12, 2019

BUY
$8.31 - $14.85 $79,069 - $141,297
9,515 Added 9.58%
108,799 $1.01 Million
Q3 2018

Nov 14, 2018

SELL
$10.49 - $13.72 $191,337 - $250,252
-18,240 Reduced 15.52%
99,284 $1.26 Million
Q1 2018

May 15, 2018

BUY
$5.9 - $14.99 $282,674 - $718,185
47,911 Added 68.82%
117,524 $1.6 Million
Q2 2017

Aug 16, 2017

BUY
N/A
69,613
69,613 $652,000

Others Institutions Holding CCXI

About ChemoCentryx, Inc.


  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Public Employees Retirement System Of Ohio Portfolio

Follow Public Employees Retirement System Of Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.